Amino acid substitution of the membrane-proximal external region alter neutralization sensitivity in a chronic HIV-1 clade B infected patient

• Published in: Virus research 2024-07, Vol.345, p.199377-199377, Article 199377
• Main Authors: Fu, Yuyu, Wang, Shuhui, Hao, Yanling, Li, Dan, Ren, Li, Wang, Zheng, Chen, Ran, Tang, Wenqi, Shen, Xiuli, Ni, Wanqi, Shi, Yutao, Zhu, Meiling, Shao, Yiming, Liu, Ying
• Format: Article
• Language: English
• Subjects: HIV-1; MPER; Mutation; Neutralization sensitivity
• ISSN: 0168-1702; 1872-7492
• DOI: 10.1016/j.virusres.2024.199377

•The highly conserved MPER region also exhibits variability.•N671S mutation increased viral neutralization sensitivity to 2F5 and 10E8.•K677R increased viral resistance to 10E8, while K677N enhanced viral resistance to 4E10 and 10E8.•Amino acid characterization of the extra-MPER also affects the neutralization sensitivity of the MPER. The membrane-proximal external region (MPER) represents a highly conserved region of the Human Immunodeficiency Virus (HIV) envelope glycoprotein (env) targeted by several broadly neutralizing antibodies (bnAbs). In this study, we employed single genome amplification to amplify 34 full-length env sequences from the 2005 plasma sample of CBJC504, a chronic HIV-1 clade B infected individual. We identified three amino acid changes (N671S, D674N, and K677R) in the MPER. A longitudinal analysis revealed that the proportion of env sequences with MPER mutations increased from 26.5 % in 2005 to 56.0 % in 2009, and the sequences with the same mutation clustered together. Nine functional pseudoviruses were generated from the 34 env sequences to examine the effect of these mutations on neutralizing activity. Pseudoviruses carrying N674 or R677 mutations demonstrate increased sensitivity to autologous plasma and monoclonal antibodies 2F5, 4E10, and 10E8. Reverse mutations were performed in env including N674, R677, D659, and S671/N677 mutations, to validate the impact of the mutations on neutralizing sensitivity. Neutralization assays indicated that the N671S mutation increased neutralization sensitivity to 2F5 and 10E8. The amino acid R at position 677 increased viral resistance to 10E8, whereas N enhanced viral resistance to 4E10 and 10E8. It has been proposed that critical amino acids in the extra-MPER and the number of potential N-like glycosylation sites (PNGSs) in the V1 loop may have an impact on neutralizing activity. Understanding the mutations and evolution of MPER in chronically infected patients with HIV-1 is crucial for the design and development of vaccines that trigger bnAbs against MPER.